In Loving Memory of Elmer Cranton, MD: 1932-2021
- Editor’s note: My next door neighbor introduced me to Dr. Cranton in 1989 when investigating the potential of moving his clinic from Troutdale, VA. to Yelm.
- Dr. Cranton used my neighbor’s large, enclosed garage as his clinic’s domicile until a Yelm office opened.
- I was given his 1989 Textbook on Edta Chelation Therapy, Volume 2 No 1-2: Special Issue of Journal of Advancement in Medicine, which intrigued me, as he outlined a non-invasive treatment for a whole host of issues that cause heart bypass surgeries, macular degeneration, etc.
- Dr. Cranton wrote this EDTA textbook for physicians, with a Forward by Dr. Linus Pauling, Ph.D., one of the founders of the fields of quantum chemistry and molecular biology, and the only person ever to receive two unshared Nobel Prizes — for Chemistry (1954) and Peace (1962). Cranton opened his Mt. Rainier Clinic in Yelm in 1990.
- I had a consultation with him soon after about his book’s claim that EDTA Chelation Therapy could be used as a preventative for Macular Degeneration, which ran in my family. I was convinced to begin his protocol, for which I have been a patient for 32 years.
- I was one of his Yelm clinic’s first patients and throughout the years, I was fortunate to learn much from Dr. Cranton, and to hear the amazing stories of healing from his patients who came to Yelm form all over the world.
- In Novmember 2010, this blog announced that Dr. Cranton and his son sold their clinic and the new owners would subsequently transfer Yelm patients to their Gig Harbor location in March 2011. I continued my treatments there until recently. To-date, I have no signs of macular degeneration.
- Dr. Cranton gave much to this community and is remembered for his remarkable achievements, which Dr. Linus Pauling, Ph.D., a 2-time Nobel Prize winner, acknowledged.
- I was honored to have known Dr. Cranton, appreciated his friendship, and called on his counsel for over 30 years!
- Blessings to his family.
Elmer Mitchell Cranton, M.D., passed away Sunday, Nov. 28, 2021, at the age of 89. He was born in Haverhill, Massachusetts on Sept. 17, 1932.
Elmer joined the U.S. Navy after high school and trained as a Navy pilot during the Korean War. During his Naval tenure, he served as the commanding officer at Byrd Station in Antarctica.
He attended the University of Colorado and received his medical degree from Harvard Medical School in 1964. He practiced medicine in California and Virginia before moving to Washington in 1990.
Beyond his successful clinical practice, he founded a nutritional supplements company and is an internationally published author. A brilliant thinker and clinician with a remarkable range of knowledge, he was also an entrepreneur and innovator.
Dr. Cranton is survived by his wife Nancy; his three daughters Anne, Catherine and Jennifer, and their spouses; his 10 grandchildren; and his two brothers Norman and Hartley.
He was well loved by his family and his patients. Time spent in the outdoors brought him peace and joy and he shared this appreciation and sense of adventure with his family. Dr. Cranton will be remembered for his service to others.
A celebration of life will be held in July 2022.
Intravenous Chelation therapy is a medical treatment used for cardiovascular heart disease by improving metabolic and circulatory function by removing toxic metals such as Lead, Cadmium, Arsenic, Aluminum, Uranium, and abnormally located nutritional metallic ions such as copper and iron from the body. Heavy metals contribute to plaque in the arteries, loss of memory function; adversely affect vital organs such as the liver, thyroid, parathyroid, and heart. It can depress immune systems as well as brain function. What is IV Chelation therapy? This is a therapy administered by an intravenous infusion of a synthetic amino acid, ethylene-diamine-tetra-acetic acid (EDTA). In Dr. Elmer Cranton, M.D.’s book “Bypassing Bypass Surgery” he states many reasons for Chelation intravenous (IV) therapy. EDTA controls free radical damage that destroys cells as it removes heavy metals, restoring normal enzyme functioning. EDTA controls oxidative damage to cell membranes and enhances the efficiency of energy metabolism, independent of any effect on blood flow or oxygen. The intravenous therapy removes excess metal ions, redistributes abnormally high concentrations of essential nutritional trace elements in blood-deprived tissues, helps reestablish prostaglandin hormone balance which reduces arterial spasm, blood clots, plaque formation and arthritis; protects the integrity of blood platelets, normalizes calcium metabolism, intermittently lowers serum calcium by stimulating uptake of calcium in bones, increases tissue flexibility and encourages overall metabolic efficiency due to the whole range of above mentioned factors.